chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The employee came down to our office and said that he was here for Hep B. The person checking him in ordered a hep b vaccine. I didn't check the task for him and gave him the vaccine after I went over the information with him. I told him that he should come back in 2 months and that we would draw his Hep B titer to see if he had immunity. He told me that he wasn't going to be here in 2 months so I went into his tasks to push out the follow up date, and noted that he actually needed the Hep B titer not the Hep B booster.
The vaccine triggered an outbreak of guttate psoriasis. Also, the 2nd dose, made some of my bottom teeth hurt (mildly) - 3 of them. I continued to take all my medications after receiving the 1st and 2nd does of the vaccine, including the Rinvoq.  Note that the 1st vaccinator was not trained to write legibly so I'm not sure if the lot # of Vaccine # 1 is correct.
some areas are red; rash under the breast/ it got worse and expanded to the side of neck / it got worse and expanded to the side of torso; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash under the breast/ it got worse and expanded to the side of neck / it got worse and expanded to the side of torso) and ERYTHEMA (some areas are red) in a 55-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included Medication for high blood pressure for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced RASH (rash under the breast/ it got worse and expanded to the side of neck / it got worse and expanded to the side of torso). On 30-Jan-2021, the patient experienced ERYTHEMA (some areas are red). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) from 30-Jan-2021 to 01-Feb-2021 at an unspecified dose and frequency. At the time of the report, RASH (rash under the breast/ it got worse and expanded to the side of neck / it got worse and expanded to the side of torso) and ERYTHEMA (some areas are red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient reported "On Saturday 30Jan2021 it got worse and expanded to the side of neck and side of torso" Patient reported "the rash under the breast is now gone"
After vaccines were administered pt got pale and was about to faint advised pt to lay down pt layed down I went to get water came back gave pt water father stated that when I was getting water Pt had a seizure like symptom when I was back in the room pt was same as when I left just felt nausea.
evening p/vax site hot, red, edematous day 2 p/vax; inner aspect rt arm red & hot to elbow;3x2.5 edematous red, hot area at & above elbow w/scattered red 3" down lower arm;day 3 PM cleared;
Lump at injection site, feels tender and is somewhat reddened but not warm or infected feeling.
Two days later I developed fever and shaking and headache; Two days later I developed fever and shaking and headache; Two days later I developed fever and shaking and headache; This is a spontaneous report from a contactable healthcare professional. A 47-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on her left arm on 22Jan2021 09:00 at a single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included terconazole, duloxetine hydrochloride (CYMBALTA), fluconazole. The patient reported that two days later, she developed fever and shaking and headache; all on 24Jan2021 11:00AM. No treatment was received for the events. The outcome of the events was not recovered.  Information on the Batch/Lot number has been requested.
rash occurred, and she noticed a rash on the inside of her elbow/ her body, thighs, calves, hip/rashes on her body/rash all over her body; rash was now raised, itchy and sore, like patches; rash was now raised, itchy and sore, like patches; This is a spontaneous report from a Pfizer sponsored program   A contactable female consumer (patient) reported for herself. A 61-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, batch/lot number: EN6208, expiry date: 30Jun2021) via unknown route of administration on 13Mar2021 (at the age of 61-year-old) as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 29Mar2021 after vaccination, rash occurred, and she noticed a rash on the inside of her elbow/ her body, thighs, calves, hip/rashes on her body/rash all over her body; and rash was raised, itchy and sore, like patches. It was reported at first, she did not think it was because of the vaccine. She was not sure if it was a side effect or if it was because of the body wash that she used. She called the other day to see if anyone else had reported a rash. Now the rash was all over her body. The rash was on her whole arms, thighs, legs, hips, and stomach. The rash had been spreading since Monday. The rash was raised, itchy and sore, like patches. She was due to have her second dose of the covid vaccine on 03Apr2021, Saturday. She did look at the CDC's website and saw listed a COVID 19 arm rash. It indicated that was no problem and she should get the second dose. She asked for advice on whether or not she should get the second dose of the covid vaccine. She stated she believes she filed a report previously, but she did not mean to. At the time of this report the outcome of the events were unknown.  No follow-up attempts were needed. No further information was expected.
Received second shot on Thursday (4-29-21) Woke up with symptoms on Friday(4-30-21). Left arm redness and tenderness that's spreading down my arm.  It's hot to touch.  Fatigue Chills  Fever Nausea.  Has not gotten better (5-3-21)
Baby stopped growing at 6 weeks 5 days and miscarried at 10 weeks 6 days.
I had a severe headache that started in the back of my head and continued for several days.   I had severe body aches and pains all over and I could hardly stand up.   Then at the height of my headache I began to feel pain in my neck and right shoulder.  By Saturday I could not move my neck or right arm and I was in extreme pain and went to the emergency room.
COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old male patient received BNT162b2 (BNT162B2), on 14Mar2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 04Apr2021 as dose 2, single (Batch/Lot number: unknown), in right arm, on 25Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown), in right arm and on 20May2022 at 13:00 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: ATORVASTATIN, start date: 16Sep2020, stop date: 08Jul2022. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 ". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of drug ineffective, suspected covid-19. Clinical course: no known allergies.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Client received the 1st dose of Moderna COVID vaccine lot # 017C21A and expiration date 5/23/21 at 1:16pm.  Client walked over to PHN to report she had a palpitation and that it had already resolved.  At 1:18pm vitals: blood pressure:128/84, pulse:96, and oxygen:99%. Client is sitting up in chair alert and oriented x 4. Client reports her medical history includes anxiety and depression. Client reports no allergies and that client recently stopped taking depression medication 2 weeks ago and anxiety medication 1 month ago. Client reports eating breakfast.  Client denies any symptoms at the moment. At 1:19pm client reports her mouth feels dry. PHN  brings a water to client.  At 1:22pm client reports her hands feel colder than usual.  EMT brings client a glove to attempt to warm hand up.  Client reports no shortness of breath, no headache, no blurred vision, no dizziness, no nausea, no chest pain, mouth feels less dry-client reports dryness she feels is similar to "how your mouth feels when you're anxious."  At 1:32pm vitals: blood pressure:130/80, pulse:101, and oxygen: 100%. Client reports she "feels nervous" and her mouth is no longer dry and no other symptoms. Client reports she is a "little nervous and has had palpitations in the past." Encourage client to follow up with provider about palpitations. At 1:38pm vitals: blood pressure:120/80, pulse:93, and oxygen:99%. Client reports no symptoms and finished water.  At 1:43pm vitals: blood pressure:120/70, pulse:85, and oxygen:100%.  Client alert and oriented and reports feeling a "little nervous".  At 120/80pm vitals: blood pressure:120/80,  pulse:95, and oxygen:100%. Client reports she is ready to leave.  PHN review ER precautions. Client walked out with a steady gait at 1:50PM
Plaintiff was treated by a healthcare provider for shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and referring to male patient of unknown age. The patient's medical history, concurrent condition and concomitant medication were not provided.   On or about 16-AUG-2017 the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, route, batch/lot number and expiration date were not provided) for long-term prevention of shingles and/or zoster-related conditions.  On an unknown date (reported as subsequent to patient's zoster vaccine live (ZOSTAVAX) inoculation), the patient experienced shingles. The patient was treated by a healthcare provider.  As a direct and proximate result of patient's use of zoster vaccine live (ZOSTAVAX) vaccine, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future.     The outcome of shingles was considered as not recovered. The reporter considered shingles to be related to zoster vaccine live (ZOSTAVAX).
Redness that grew in size rapidly, hot, and hard to touch from shoulder to elbow. Went to ER was diagnosised with cellulitis and treated with IV antibiotics and went home with oral antibiotics.
Area on right arm red, swollen, warm 5"x3". Smaller dark area inside red area 3"x2"; slight fever reported. Normal; now took Tylenol.
8 hours after injection patient experienced fever rash (6 inches), nausea. (Patient is a retired doctor he decided not to go to his doctor).
LUMP AT THE INJECTION SITE (QUARTER SIZE OR BIGGER LUMP); DISCOMFORT AT INJECTION SITE; ARM/HAND NUMBNESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included factor v leiden mutation. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, expiry: UNKNOWN) dose was not reported, administered on 22-MAR-2021 for prophylactic vaccination. Concomitant medications included rivaroxaban for pulmonary embolism bilateral lungs, and deep vein thrombosis right side. On an unspecified date, the subject experienced lump at the injection site (quarter size or bigger lump), discomfort at injection site, and arm/hand numbness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the lump at the injection site (quarter size or bigger lump), discomfort at injection site and arm/hand numbness was not reported. This report was non-serious.
1st day-  left arm burn, 1 week later- left arm swollen, huge rash, welted arm (full upper arm away from area of shot)    2 days later- couldn't move arm, neck pain, tingling down arm to finger tips 4 days later - chest tight, shortness of breath, fast heart rate, fatigue (this is continuous)  pt is seeing cardiologist and allergist and has not received 2nd shot yet
rash on the injected arm; swollen lymph node in arm; felt really sick; Nausea; high fever; chills; heart palpitations/"it felt like my heart pounding out of the chest; little chest pain; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (heart palpitations/"it felt like my heart pounding out of the chest), CHEST PAIN (little chest pain), ILLNESS (felt really sick), NAUSEA (Nausea) and PYREXIA (high fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Sep-2021, the patient experienced PALPITATIONS (heart palpitations/"it felt like my heart pounding out of the chest) and CHEST PAIN (little chest pain). On 21-Sep-2021, the patient experienced ILLNESS (felt really sick), NAUSEA (Nausea), PYREXIA (high fever) and CHILLS (chills). On 23-Sep-2021, the patient experienced RASH (rash on the injected arm) and LYMPHADENOPATHY (swollen lymph node in arm). On 21-Sep-2021, PALPITATIONS (heart palpitations/"it felt like my heart pounding out of the chest) and CHEST PAIN (little chest pain) had resolved. On 22-Sep-2021, ILLNESS (felt really sick), NAUSEA (Nausea), PYREXIA (high fever) and CHILLS (chills) had resolved. At the time of the report, RASH (rash on the injected arm) outcome was unknown and LYMPHADENOPATHY (swollen lymph node in arm) was resolving.     Concomitant medication was not reported.  Patient noticed she had a rash on the injected arm, but not at the injection site but on the inside elbow.   Treatment information include put some ice on swollen lymph node and it went down.
admitted for seizures. intubated in ER. per mom, SOB and difficulty swallowing x 2 weeks; ETOH withdrawal seizures. keppra, no covid treatments-not symptomatic.  extubated 12/31 placed on cpap. wean as tolerated until dc'd home.
Headache (pain: 2 out of 10). Affected vision: as if just looked into bright light bulb.  Pixellated, some parts of the picture were smudged.
Information has been received from a physician concerning a 2 month old pt with a history of an ear infection who on 9/7/06 was vaccinated PO with a 2.0 ml dose of Rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human Bovine). Concomitant vaccinations administered on that same day included a dose of Pediarix, a dose of Prevnar and a dose of Hib conj vaccine. The physician reported that on 9/7/06, the pt developed a high fever. Unspecified medical attention was sought. At the time of this report, the pt was recovering. Additional information has been requested.
Hives on legs and trunk starting the day of the vaccine and continuing for 4 additional days.  Still present as of this submission. Taking Antihistamines. Antihistamines reduce severity.
On march 20th after my first covid-19 vaccine I donated blood at blood center. On march 30 I was informed that my blood sample tested as a false positive for HIV. Upon retesting my sample tested negative for HIV. I most have not previously had a false positive for HIV
ACHES; A FEW DAYS WITH FEVER; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. As per procedure no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced aches, and a few days with fever. The action taken with covid-19 vaccine was not applicable. The outcome of the a few days with fever and aches was not reported. This report was non-serious. This case, from the same reporter is linked to 20210626803.
This literature market report has been received from the authors of a published literature article, concerning a 23 year old male patient, who was a medical student. The patient had lifted weights with a sports team. The patient had received 2 doses of childhood MMR (manufacturer unknown) (lot#, dose and route unspecified) vaccinations. On an unknown date, the patient presented with orchitis. Fever was the second most common symptom, followed by upper respiratory symptoms. At the time of the initial student health visit, the patient was found to have high mumps immunoglobulin G (IgG) levels of greater than 4 index (positive was >= 1.10) and negative immunoglobulin M (IgM) levels (< 1:20). The patient had a negative buccal swab mumps virus ribonucleic acid (RNA) reverse transcription polymerase chain reaction (RT-PCR). The outcome of the event was unknown. The reporter considered orchitis to be related to MMR (manufacturer unknown). This is one of several reports received from the same source (linked with MARRS # 1608USA002099, 1608USA015163, 1608USA015164). Additional information has been requested.
She received the Moderna COVID vaccine on 12/22/2020. She had no initial problems with the vaccine. Had a little soreness in the arm of the injection, but otherwise fine. Today, she has noticed itching and redness around the injection site. Located on the left shoulder.
Anaphylactic shock; Potassium "dropped to 1%"; Cold and numb sensation; Sweating; Chest pressure; Blood pressure was 223/105-110; Neck swelling; Numb lips; Throat swelling; Disability NOS; A spontaneous report was received from a 69-year-old, female, patient who received Moderna's COVID-19 Vaccine (mRNA-1273), and experienced anaphylactic shock, potassium dropped to 1%, cold and numb sensation, sweating, chest pressure, blood pressure was 223/105-110,Neck swelling, Throat swelling, Numb lips and disability.  The patient's medical history, as provided by the reporter, included allergies to yellow 5 (tartrazine), shellfish, and bee stings. Concomitant product use was not provided by the reporter.  On 19 Jan 2021 at 11:42 AM, approximately two minutes prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the left arm for prophylaxis of COVID-19 infection.    On 19 Jan 2021, minutes after receiving the vaccine, the patient experienced a cold and numb sensation on the upper right part of her back. The sensation extended around her shoulder and into her clavicle region. Approximately 30 minutes after vaccination she started sweating and felt like she was going into anaphylactic shock, which she had experienced in the past. The patient felt like her throat was swelling and her neck started to visibly swell. One hour after vaccination, the patients lips went numb, the clavicular numbness continued, and she started to experience chest pressure. A paramedic then evaluated the patient, her blood pressure was 223/105-110 mmHg, she was placed in an ambulance, given diphenhydramine and solumedrol, then taken to the emergency room. At the emergency room, the patient received a chest x-ray, computed tomography scan, blood tests, and an electrocardiogram. Previously, the patient had a blood test which showed a potassium of 4.3 to 3.9 "or something." At the emergency room, her potassium had "dropped to 1%." The patient was administered potassium in the hospital and was held for observation until approximately 10:00 PM, then discharged.   On 20 Jan 2021, the patient continued to experience chest tightness.  Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events anaphylactic shock, potassium dropped to 1%, cold and numb sensation, sweating,blood pressure was 223/105-110 ,Neck swelling, Throat swelling, Numb lips and disability was unknown. The event, chest pressure was considered not resolved.; Reporter's Comments: This case concerns a 69-year-old, female patient with medical history of allergies to yellow 5 (tartrazine), shellfish, and bee stings, who experienced a serious, unexpected event of anaphylactic shock, sweating, hypoaesthesia, pharyngeal swelling, neck swelling, numb lips, chest discomfort, hypertension, hypokalemia and disability NOS. The event occurred the day the first dose of mRNA-1273 was administered. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Mom insisted that he developed a papule that turned into Impetigo that has spread. I started him on antibiotics today. Mom was applying band aids and triple antibiotics and although it is spreading it seems to be healing x 24 hrs on meds. Rash is not pruritic.
Information has received from a physician concerning a 15 year old female patient with no known allergies, who on 09-SEP-2008 was vaccinated with the third dose of GARDASIL.  Concomitant therapy included ADDERALL.  On 13-SEP-2008, the patient experienced shortness of breath.  The patient experienced a second period of shortness of breath three weeks later (approximately on 04-OCT-2008).  On an unknown date, the patient recovered from shortness of breath.  The patient sought medical attention in an office visit.  Additional information has been requested.
Phone call from mother on 8/11 - reported to LPN that patient was "dizzy", "face swelled up", "very itchy", "eye lids puffy".  Patient given Benadryl and Tylenol.  Phone call to mother 8/13.  She verifies same symptoms - occurring approximately 15 minutes after injection.  Patient did go to work - return home at 10:30 with same complaints.  Given Tylenol/Benadryl per direction.  Phone call to ER.  Nurse continued with same Benadryl and Tylenol until symptoms gone on Sun. 8/13 - still having complaints of headache.  No problems with breathing noted per mother.
redness, induration & pain (persistent)-site still persistent redness, induration & pain;MD feels that perhaps dose of vax may have been given SC;
Information has been received from a physician concerning a couple of patients who were vaccinated with Gardasil vaccine. The physician reported that the patients experienced burning at the injection site. No further information for any of the patients was reported. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. Additional information has been requested.
I began to feel the onset of the AE the next morning at around 3:00 AM after the vaccination. Generalize pain throughout my body, muscle aches,   slight fever, muscular skeletal pain  and general feeling of being extremely tired, and I feel like I have brain fog . Asthma and fibro maylagia are worse since I had the vaccination,  sinuses I'm constantly congested. I feel more tired now than I did previously. I will never take this Pfizer vaccination again.  My symptoms are not as bad as the week after the vaccination but  I have not felt normal or as I did prior to the vaccination.